Qasim Abdallah, Mansour Mohamed, Kousa Omar, Awad Dana, Abuhazeem Bader, Millner Paul, Velagapudi Manasa
Department of Internal Medicine, Creighton University, NE, United States.
Department of Internal Medicine, Sheikh Shakhbout Medical City, Abu Dhabi, United Arab Emirates.
Intractable Rare Dis Res. 2020 Nov;9(4):256-259. doi: 10.5582/irdr.2020.03081.
Coronavirus disease 2019 (COVID-19) is a respiratory illness caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus that was identified in December 2019. The impact of COVID-19 virus on Acquired Immunodeficiency syndrome (AIDS) patients has been reported with variable outcome. We reported a patient that was immunosuppressed by AIDS disease and chemotherapy for cancer who contracted SARS-CoV-2 infection and had a mild disease. We did literature review for the cases published that had human immunodeficiency virus (HIV) infection and COVID-19 disease and analyzed the characteristics and outcomes of the reported cases. Our review yielded three case reports and four case series for patients with HIV infection and COVID-19 disease. The majority of patients had mild disease, and some had critical disease or death. Those who had severe disease usually had other comorbidities. The findings from the case reports and case series indicate that the risk of death or severe disease from COVID-19 in HIV positive patients was lower than observed in the general population, which may indicate a possible protective effect of uncontrolled HIV in preventing the complications associated with the massive inflammatory response.
2019冠状病毒病(COVID-19)是一种由严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引起的呼吸道疾病,该病毒于2019年12月被发现。COVID-19病毒对获得性免疫缺陷综合征(AIDS)患者的影响已有不同结果的报道。我们报告了一名因艾滋病和癌症化疗而免疫抑制的患者,该患者感染了SARS-CoV-2且病情较轻。我们对已发表的人类免疫缺陷病毒(HIV)感染和COVID-19疾病的病例进行了文献综述,并分析了报告病例的特征和结果。我们的综述得出了3例病例报告和4例HIV感染合并COVID-19疾病的病例系列。大多数患者病情较轻,部分患者病情危重或死亡。病情严重的患者通常有其他合并症。病例报告和病例系列的研究结果表明,HIV阳性患者因COVID-19死亡或患重病的风险低于普通人群,这可能表明未得到控制的HIV在预防与大规模炎症反应相关的并发症方面可能具有保护作用。